Amoolya Gowda

Weekly Icodec versus Daily Glargine U100 in Type 2 Diabetes without Previous Insulin

Julio Rosenstock, Stephen C. Bain, Amoolya Gowda et al. · New England Journal of Medicine · 2023 · 149 citations

Medicine, Pharmacology, Pharmacotherapy +16

Switching to Once-Weekly Insulin Icodec Versus Once-Daily Insulin Glargine U100 in Type 2 Diabetes Inadequately Controlled on Daily Basal Insulin: A Phase 2 Randomized Controlled Trial

Harpreet S. Bajaj, Richard M. Bergenstal, Andreas Christoffersen et al. · Diabetes Care · 2021 · 124 citations · Full text

Medicine, Endocrinology, Pharmacotherapy +17

Once-Weekly Insulin Icodec With Dosing Guide App Versus Once-Daily Basal Insulin Analogues in Insulin-Naive Type 2 Diabetes (ONWARDS 5)

Harpreet S. Bajaj, Jens Aberle, Melanie J. Davies et al. · Annals of Internal Medicine · 2023 · 82 citations

Medicine, Endocrinology, Pharmacotherapy +11

Rationale and design of the phase 3a development programme ( <scp>ONWARDS</scp> 1–6 trials) investigating once‐weekly insulin icodec in diabetes

Athena Philis‐Tsimikas, Harpreet S. Bajaj, Kamilla Begtrup et al. · Diabetes Obesity and Metabolism · 2022 · 76 citations · Full text

Medicine, Endocrinology, Pharmacotherapy +15

Hemoglobin glycation index, calculated from a single fasting glucose value, as a prediction tool for severe hypoglycemia and major adverse cardiovascular events in DEVOTE

Klara R. Klein, Edward Franek, Steven P. Marso et al. · BMJ Open Diabetes Research & Care · 2021 · 46 citations · Full text

Medicine, Endocrinology, Internal Medicine +17